2 AI Surgery Stocks to Buy Hand Over Fist in February

Core Viewpoint - Investors are optimistic about the future of AI stocks, driven by the expectation that AI will increasingly integrate into various aspects of life, including surgery [1] Group 1: AI Surgery Opportunities - AI technology is being utilized to assist human doctors in surgical procedures, indicating a growing trend in AI surgery [2] - Intuitive Surgical is a leading company focused solely on surgical robotics, with a significant increase in the installation of its da Vinci surgical robots, from 1,526 in 2024 to 1,721 in 2025, representing a nearly 13% increase [3] - The total number of da Vinci surgical robots in operation reached 11,106 by the end of 2025, marking a 12% year-over-year increase [3] Group 2: Demand and Growth Projections - The demand for surgical robots is strong, with surgeries performed using the da Vinci system increasing by 18% year-over-year in 2025, and an expected rise of up to 15% in 2026 [4] - The FDA has approved an AI tool to assist surgeons in making real-time adjustments during lung surgeries, showcasing the integration of AI in surgical practices [4] Group 3: Investment Considerations - Intuitive Surgical presents a high-risk, high-reward opportunity for aggressive growth investors, despite its high valuation with a price-to-earnings (P/E) ratio of 67 [5] - Medtronic offers a more diversified investment option with a lower P/E ratio of 27, although it is set to spin off its diabetes division soon [6]